Electromed, Inc. (ELMD) Cash Flow Statement

NYSE American: ELMDOperating cash, capex, free cash flow and buybacks.

Where ELMD’s cash came from and went, FY2026

June 30, 2026 · U.S. dollars
Cash from operations
$9.7M
−15.2% vs FY2025
Capital expenditures
$1.3M
1.7% of revenue
Free cash flow
$8.4M
11.4% margin
Returned to shareholders
$3.9M
47% of free cash flow
Change in cash
$5.2M
cash at year-end $20.4M
Cash from operations: $9.7MCash from operations$9.7MOther financing: $716,000Other financing$716,000Share buybacks: $3.9MShare buybacks$3.9M · 38%Capital expenditures: $1.3MCapital expenditures$1.3M · 12%Added to cash: $5.2MAdded to cash$5.2M · 50%Acquisitions & other: $48,000Acquisitions & other$48,000 · 0%$10.4M
Cash from operations
$9.7M
Capital expenditures
−$1.3M
Acquisitions & other
−$48,000
Share buybacks (net)
−$3.9M
Other financing
+$716,000
Change in cash
$5.2M

Drawn to scale: where the cash came from and how it was used. Hover for values.

ELMD operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

ELMD cash flow trends, FY2017–FY2026

Electromed, Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow$1.2MFY2017$9.7MFY2026+26.2%/yr
Capital expenditures$687,148FY2017$1.3MFY2026+6.9%/yr
Free cash flow$503,973FY2017$8.4MFY2026+36.7%/yr
Free cash flow margin1.9%FY201711.4%FY2026+9.5 pts
Operating cash flow / net income0.53FY20170.86FY2026+0.32
Stock-based compensation$479,482FY2017$2.7MFY2026+21.3%/yr
Dividends paid$0FY2017$0FY2018—
Share buybacks (net)$0FY2017$3.9MFY2026—
Capex / revenue2.7%FY20171.7%FY2026−1.0 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ELMD cash flow by activity

OperatingInvestingFinancingChange in cash

ELMD net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

ELMD cash flow statement

Electromed, Inc. annual cash flow statement
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating activities
Net income$11.3M$7.5M$5.2M$3.2M$2.3M$2.4M$4.2M$2.0M$1.9M$2.2M
Depreciation & amortization$1.1M$1.2M$841,000$613,000$628,000$610,000$741,000$925,227$790,027$755,127
Stock-based compensation$2.7M$3.1M$1.7M$708,000$976,000$1.0M$902,000$924,071$862,674$479,482
Change in working capital−$5.9M−$277,000$2.0M−$3.1M−$4.1M−$625,000−$1.5M−$981,626−$1.0M−$2.3M
Other non-cash items$426,000−$98,000−$571,000−$43,000−$489,000−$294,000−$126,000−$247,016−$97,537$32,093
Cash from operating activities$9.7M$11.4M$9.1M$1.3M−$686,000$3.1M$4.2M$2.6M$2.4M$1.2M
Investing activities
Capital expenditures−$1.3M−$306,000−$395,000−$1.7M−$1.5M−$448,000−$977,000−$1.4M−$571,777−$687,148
Investments (net)—−$306,000−$395,000−$1.7M−$1.5M−$448,000−$977,196−$1.4M−$571,777−$687,148
Acquisitions & other investing−$48,000$306,000$395,000$1.7M$1.5M$448,000$977,196$1.4M$571,777$687,148
Cash from investing activities−$1.3M−$306,000−$395,000−$1.7M−$1.5M−$448,000−$977,000−$1.4M−$571,777−$687,148
Financing activities
Dividends paid————————$0$0
Share repurchases & issuance (net)−$3.9M−$10.0M−$275,000−$153,000−$1.4M−$1.1M−$628,000$251,849$62,412$0
Net borrowing (repayment)———————−$1.1M−$50,700−$53,619
Shares issued$0$0$0$0$0$0$0$0$0$0
Other financing$716,000−$1.9M$311,000−$227,000−$77,000−$95,000$80,000$0$0$0
Cash from financing activities−$3.2M−$11.9M$36,000−$380,000−$1.5M−$1.2M−$548,000−$851,152$11,712−$53,619
Summary
Net change in cash$5.2M−$793,000$8.7M−$781,000−$3.7M$1.4M$2.7M$352,084$1.9M$450,354
Cash at end of period$20.4M$15.3M$16.1M$7.4M$8.2M$11.9M$10.5M$7.8M$7.5M$5.6M
Free cash flow$8.4M$11.1M$8.7M−$401,000−$2.2M$2.6M$3.2M$1.2M$1.9M$503,973
Free cash flow margin11.4%17.3%15.8%−0.8%−5.3%7.4%9.9%3.8%6.6%1.9%
Capex / revenue1.7%0.5%0.7%3.6%3.7%1.3%3.0%4.4%2.0%2.7%
Operating cash flow / net income0.861.511.760.42−0.301.301.011.321.280.53

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

ELMD cash generation

In fiscal 2026 (ended June 30, 2026), Electromed generated $9.7 million of cash from operations (down 15.2%) and spent $1.3 million on capital expenditures, leaving free cash flow of $8.4 million, 11.4% of revenue. It returned $3.9 million to shareholders through dividends ($0) and net share buybacks ($3.9 million). Cash and equivalents rose by $5.2 million over the year.

Related: ELMD income statement, ELMD balance sheet. See the ELMD stock overview for the latest quote and news.

ELMD cash flow FAQ

What is Electromed's free cash flow?

Electromed's free cash flow was $8.4 million in fiscal 2026: $9.7 million of operating cash flow minus $1.3 million of capital expenditures It was $11.1 million a year earlier..

How much cash does Electromed generate from operations?

Electromed generated $9.7 million of cash from operating activities in fiscal 2026, 0.86 times its net income of $11.3 million.

How much does Electromed spend on capital expenditures?

Electromed spent $1.3 million on capital expenditures in fiscal 2026, 1.7% of revenue, compared with $0.3 million the year before.

How much stock does Electromed buy back?

Electromed spent $3.9 million on net share repurchases in fiscal 2026.

Medical Devices: cash flow